Probiotics Inhibit Cartilage Damage and Progression of Osteoarthritis in Mice.

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

[Indexed for MEDLINE] Conflict of interest statement: Professor Ralston reports funding to his institution from Abbvie, Alexion, Amgen, Bristol Myers Squibb, Cellgene, Janssen-Cilag, Kyowa Kirin, Novartis, Pfizer, Sanofi-Genzyme, Sandoz, UCB, and Thornton and Ross; and research funding to his institution from Astra Zeneca and UCB, outside the submitted work. Dr Sophocleous and Professor Ralston are inventors of a patent concerning the use of probiotics in the treatment of osteoarthritis in mammals filed by Probi AB (WO2020212528). The other authors report no conflicts of interest.